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ABSTRACT
Background. Canine tracheal collapse is a complex airway pathologywithout promising
treatment results. Currently nitinol stents are the best surgical option; however, some
professionals are doubting if stent placement is the best option due to the associated
complications.
Objective. Determine the technical feasibility, safety, and long-term follow-up after the
implantation of a new tracheal stent designed for canine tracheal collapse.
Methods. Thirteen healthy, adult female New Zealander rabbits were involved in this
pilot study. A new intra-tracheal device (Reference number 902711 patent registered
as CasMin-Twine) was implanted in ten animals. Deployment was performed under
general anesthesia, making a puncture incision via a 21 Gauge needle in the intra-
tracheal space where the stent was introduced with a screwing process. The device was
fixed to the tracheal wall with a non-absorbable suture. Computerized Tomography
(CT) and an endoscopy to study structural abnormalities were performed after 30, 90
and 365 days after stent placement.
Results. Technical and clinical success was 100%. There was no significant change in
behavior or respiratory disorders. CT studies showed no significant alterations. After
the 30 days, 60% of the animals showed partial endothelization in the endoscopy study,
and only one animal still presented partial endothelization after 12 months. Mucus
accumulation was only present in 40%of cases and classified as low, without respiratory
consequences. Only one animal presented a single granuloma at caudal stent tip.
Conclusions. This new tracheal stent (CasMin-Twine) is an effective and safe procedure
with promising results, and also shows the possibility of removing the device after
endothelization has been produced. New studies should be carried out to evaluate the
effectiveness in patients with tracheomalacia.
Clinical Significance/Impact. This new product can give veterinarians a new option
of treatment for this complicated pathology. Minimizing specific equipment for its
deployment, CasMin-Twine will be more accessible for all professionals.
Subjects Veterinary Medicine, Respiratory Medicine
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INTRODUCTION
Canine tracheal collapse is a progressive, degenerative disease occurring mainly in middle-
aged small and toy breeds with a high incidence in small dogs and prevalence reported in
1974 about 0.5% of 2,780 dogs (Amis, 1974).
The etiology is not well understood, but it has been observed that a degeneration of
the tracheal cartilage rings as a result of hypo-cellularity and decreased glycosaminoglycan
content (Amis, 1974) that leads to cartilage weakness and loos of the C shape morphology
and laxity of the dorsal tracheal membrane can be altered, resulting in a dynamic collapse
during respiration. The disease can be focal or generalized and in many cases associated
with bronchial degeneration (Amis, 1974; Tappin, 2016; Sura & Krahwinkel, 2008; Beranek,
Jaresova & Rytz, 2014).
The clinical manifestations depend on the severity of the collapse and the affected
segment of the tracheal, which can progressively degenerate in time. Clinical symptoms
can range from an exercise intolerance with a classic ‘‘goose-honk’’ to severe respiratory
distress and syncope (Tappin, 2016; Sura & Krahwinkel, 2008; Beranek, Jaresova & Rytz,
2014; Weisse et al., 2008; Chisnell & Pardo, 2015). The diagnostic procedure is usually
performed by fluoroscopy and endoscopy. However, dynamic CT can play a major role in
the diagnosis of this pathology (Ullmann et al., 2018).
Medical management is the first option, being palliative and temporally (Tappin, 2016;
Ullmann et al., 2018). Many dogs improve with anti-inflammatory drugs, antitussives,
antibiotics, bronchodilators and weight-loss, but in high grade collapse it is usually limited.
If options for medical therapy have failed to control symptomatology, surgery should be
considered. Surgical options are also palliative, they can be varied and different according
to the collapsed area. Extra-luminal C-shaped plastic rings can be only used in non-intra-
thoracic collapse; it is an invasive surgery with associated complications. In a previous study
(Chisnell & Pardo, 2015), the technical success was 65%, with 17% of the dogs presented
laryngeal paralysis and 9% needed a second intervention. Moreover, high morbidity rates
are associated with surgical reconstruction of thoracic tracheal segments (Chisnell & Pardo,
2015; Tinga et al., 2015).
Because of these complications and the improvement of new surgical methods, various
minimally invasive techniques have been investigated for the deployment of intraluminal
devices. Currently, the use of self-expandable nitinol stents is recommended due to the
complications arising of stainless-steel stents, which include migration, shortening and
fracture. Self-expandable nitinol stents presented better results and are the treatment of
choice when medical management has failed; however, granuloma formation and stent
migration are also described as complications (Sura & Krahwinkel, 2008; Beranek, Jaresova
& Rytz, 2014;Weisse et al., 2008; Chisnell & Pardo, 2015; Ullmann et al., 2018; Clarke, 2018;
Tinga et al., 2015; Rosenheck et al., 2017; Serrano et al., 2016; Moritz, Schneider & Bauer,
2004; Chung et al., 2011).
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The search for a better intra-tracheal device is required, and long-term follow-up studies
will be necessary. In this study, we proposed an original approach for tracheal collapse,
and a new intra-tracheal device assessed in laboratory animals with a 12-month follow-up.
The main purpose of this research is to evaluate the new tracheal approach and long-term
complications arising from this new surgical technique and the safety and efficacy of the
device.
MATERIAL AND METHODS
This study was approved by the ethics committee PI26/17- University of Zaragoza, Spain.
This study was elaborated according to ARRIVE guidelines (Kilkenny et al., 2010).
Laboratory animals
A total of thirteen healthy New Zealand adult rabbits was involved in this pilot study.
The follow-up was scheduled for 12 months to analyze long-term complications. Animals
were obtained from the experimental center of our institution (University of Zaragoza),
with weights ranging between 4.2–4.5 kg. Three control rabbits (3/13) were compared
in this study. All veterinarians and personnel in charge of the animals had the required
qualifications, RD 1021/2005. The experimental animal was elected based on characteristics
already described in previous studies (Serrano et al., 2016).
Experimental procedure (Pilot study)
Experimental device
An intra-luminal spiral stent was manufactured for the treatment of tracheomalacia, with
an average length of six cm, a 5.5 mm diameter, and a 0.03 mm thickness of stainless-steel.
The measures were the same in all animals. The handmade stent for this pilot study is
described in the following figure. (Reference number 902711 registered as CasMin-Twine)
(Fig. 1).
Before CasMin-Twine implantation, a computerized tomography (CT) scan was
performed in one rabbit to measure tracheal diameter and length. Stent size was
manufactured 1:1 ratio with tracheal dimensions.
Interventional procedure
The rabbits were inducedwith a combination ofmedetomidine (0.025mg/kg intramuscular
[IM]) and ketamine (0.15 mg/kg IM), enough to place an intravenous catheter (auricular
vein) and introduce a laryngeal mask (V-Gel; Docsinnovent, London, England).
Throughout the procedure, the anesthesia was maintained via inhaled isoflurane gas
and vital parameters were monitored. It was also used 0.1 ml lidocaine intra-tracheal
(Lidocaine 5%) before the delivery of the device.
The device (CasMin-Twine) deployment was performed making a one cm dissection in
the ventral region of the neck, at one cm caudal to the cricoid cartilage. At this tracheal level,
the intra-tracheal space was punctured via a 21 Gauge needle and administrated 0.1ml of
lidocaine 5%. Through the hole made by the needle, the spiral device was introduced with a
screwing motion (clockwise) into the tracheal lumen, and the CasMin-Twine proximal tip
loop was fixed to the cranial ring with a non-absorbable suture (nylon 6.0 curved needle).
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Figure 1 CasMin Twine design. Shape of the twine. Tips characteristics: flexible tip, and tip with suture
fixation.
Full-size DOI: 10.7717/peerj.7797/fig-1
The suture is permanent, not only to fix the prosthesis to the tracheal wall but also to locate
it in case that is needed to remove the stent. The removal of the stent is possible by cutting
the fixation point and unscrewing (counterclockwise) the spiral device.
At the end of the procedure, the position of the device was visualized by fluoroscopy as
image study. The stent delivery was always positioned one cm caudal to the cricoid cartilage
and one cm cranial to the carina.
Follow-up
Clinician monthly follow-up was performed with a symptoms checklist to detect any
respiratory disorder and other parameters to assess the rabbit’s health. Two experimented
veterinarians evaluated the parameters, it included; abnormal appearance (anxiety,
depression, inactive or restless), screeches or moans teeth grinding, tonic immobility,
rejection of water and / or food and weightless. Cough, dyspnea, inspiratory or expiratory
stridor were under respiratory parameters studied and was assigned a number between
0-3, being 0 non-findings and 3 high abnormalities.
Imaging follow-up
A non-contrast-enhanced CT scan was performed after 30, 90 and 365 days (Fig. 2) as an
imaging study. Tracheal stenosis, granuloma-presence or tissue overgrowth and mucus
accumulation were evaluated. These parameters were previously defined and classified
according to previous studies published (Serrano et al., 2016).
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Figure 2 CT images. (A–B) Axial and Sagittal view before CasMin-Twine implantation. (C–D) Axial and
Sagittal view 3th month post-implantation. (E–F) Axial and Sagittal view 12th months post-implantation.
Full-size DOI: 10.7717/peerj.7797/fig-2
Tracheal stenosis was evaluated measuring intra-tracheal lumen, stent thickness and
tracheal area: 0 (non-stenosis 0%), 1 (stenosis <20%), 2 (stenosis >20%–<40%), 3 (stenosis
>40%–<60%), 4 (stenosis >60%–<80%), 5 (stenosis >80%–<100%).
The granuloma was assessed present or not, and the number of granulomas:
0(non-granuloma),1(presence of one granuloma),2(>1 granuloma).
Mucus accumulation was divided into: 0 (absent), 1 (low accumulation), 2 (moderate
accumulation), and 3 (severe retention).
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Also, the endoscopic study was performed after 30, 90 and 365 days to evaluate
macroscopic findings; inflammatory reaction, granuloma presence, mucous membrane
congestion, mucus retentions and endothelization of the prosthesis.
Endoscopy was done with a rigid 30◦, four mm optical endoscopy (Karl Storz, Hopkins
II).
Degree of endothelization was classified into three groups, visualizing tissue growth over
the stent: 0 (no-endothelization: naked stent), 1 (partial endothelization: stent areas not
covered), 2 (total endothelization).
Evaluation of mucous membrane congestion was based on erythematous tissue: 0
(non-congestion), 1 (low mucous membrane congestion: orange-colored or patched
mucosa), 3 (severe mucous membrane congestion: intense red- bloodshot).
Assessment of the inflammatory reaction was divided into 0: absent, 1: low and 2: mild
and 3: severe inflammation.
The amount of mucus retention in tracheal lumen was divided into 0: non-retention,
1: moderate; isolated mucus without air-flow problems, and 2: profuse amounts; ranging
from colorless-white appearance of whole stent with difficult airflow (Kilkenny et al., 2010).
Endotracheal granulomas were defined as 0: absent, 1 isolated granuloma and 2
numerous granulomas (Serrano et al., 2016).
Histopathology: macroscopic and microscopic study
After a period of 365 days, animals were sacrificed by intravenous administration of sodium
pentobarbital (120 mg/kg) (Dolethal; Vetoquinol, Lure, France).
The tracheal specimens were removed from the glottis to the carina for its macroscopic
evaluation, afterwards, the CasMin Twine was removed and the trachea fixed in
10% formaldehyde. Macroscopic evaluation showed neovascularization and abnormal
alterations of the surrounding tissue. Transverse histologic sections were prepared using
hematoxylin-eosin stain and were evaluated structural changes of the epithelium and signs
compatible with inflammation.
All the data were expressed as mean and SD for qualitative variables. Categorical data
were expressed as percentages. A P value of <0.05 was considered to indicate statistical
significance. Data was processed and analyzed using a computer software program for
statistical analyses with SPSS. IBM SPSS Statistics for Macintosh, Version 21.0; IBM Corp.,
Armonk, NY, USA). Qualitative variables were compared using the Likelihood Ratio test
or Fisher’s exact test.
RESULTS
The ten stented rabbits studied were successfully implanted in 100%. Mean duration of the
procedure was 20 min ± 6 min from the anesthetic induction the end of the procedure.
The follow-up after the procedure was 12 months, focused on long-term complications.
Behavior and respiratory abnormalities were noted. Two-month post-implantation 23%
(3/13) of rabbits presented respiratory stridor during the manipulation, without clinical
significance and without relation between imaging findings, and (1/13) one in the control
group presented similar symptoms without the association of the presence of tracheal stent.
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Figure 3 Endoscopic control. 12th month tracheoscopy control: Total endothelization with low mucus
retention.
Full-size DOI: 10.7717/peerj.7797/fig-3
Imaging study results were noted. On first and third month CT study did not show any
anatomical change. After 12 months only one animal implanted (10%) showed evidence
of granuloma formation in the loop of caudal tip and images compatible with low mucous
retention (Fig. 3).
Endoscopic follow-up (Table 1) showed, a partial endothelization categorized as 1 in
the 60% of cases at the first control, being total endothelization of the stent after 90 days in
4/6 animals, and in 5/6 after 360 days. Only one animal (10%) still presented areas of stent
non-endothelized after one year. No clinical worsening after stent placement was evident
in the follow-up period (365 days). Mucous membrane congestion was only visible in 20%
(two rabbits) at 90 days and graded as 1 (low congestion).
The 60% of the animals presented low mucus accumulation (category 1) at month 12
follow-up, with no significant respiratory abnormalities. Neither mucus accumulation
nor mucous membrane congestion showed significant differences with controls
(p= 1.00 p= 0.092).
In the macroscopic evaluation, in one of the implanted animals (1/10) presented
neovascularization at the stent fixation point. In 0% of the rabbits the surrounding tissue
was altered (Fig. 4).
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Table 1 Endoscopic follow-up grades.Degree of endothelization: (visualizing tissue growth over the stent) 0 (no-endothelization: naked stent), 1
(partial endothelization: stent areas not covered), 2 (total endothelization). Evaluation of mucosal congestion: 0 (non congestion), 1 (low mucosal
congestion: orange colored or patched mucosa), 3 (severe mucosal congestion: intense red- bloodshot). Assessment of the inflammatory reaction 0:
absent, 1: low and 2: mild and 3: severe inflammation. Mucus retention in tracheal lumen 0: non-retention, 1: moderate; isolated mucus without air-
flow problems, 2: profuse amounts; ranging from colorless-white appearance of whole stent with difficult air-flow. Granulomas 0 absent, 1 isolated
granuloma and 2 numerous granulomas. Implanted animals make reference to those animals with CasMin Twine implanted. Control animals were
three, they have no endothelization valued because no stent was implanted.
Implanted animals Control animals
30 days 90 days 365 days 30 days 90 days 365 days
Grade 0
Grade 1 60% (6/10) 20% /2/10) 10% (1/10)Endothelization
Grade 2 40% (4/10) 80% (8/10) 90% (9/10)
Grade 0
Grade 1 30% (3/10) 30% (3/10) 10% (1/10) 66.6% (2/3) 33.3% (1/3)
Grade 2
Congestion
Grade 3
Grade 0
Grade 1 20% (2/10) 33.3% (1/3)
Grade 2
Inflammatory reaction
Grade 3
Grade 0
Grade 1 70% (7/10) 60% (6/10 40% (4/10) 33.3% (1/3)Mucus retention
Grade 2
Grade 0
Grade 1 10% (1/10) 10% (1/10)Granuloma
Grade 2
The histological study showed mostly discrete inflammatory reaction, slight increase in
goblet cells and some areas with loss of ciliary structure. The cartilage structure was not
affected. The prosthesis-free areas of trachea maintained the normal histology structure.
The endothelization of the device was confirmed; some areas of the tracheal wall
presented holes with a new epithelium surrounding it (Fig. 5).
DISCUSSION
Tracheal collapse is a pathology whichmainly affects middle-aged small and toy dog breeds.
High collapse grade can produce serious clinical symptoms with life compromising and
negative effects on the patient but also on the owner stress.
Because of the poor results obtained in current treatments (Beranek, Jaresova & Rytz,
2014; Chisnell & Pardo, 2015; Clarke, 2018; Chung et al., 2011; Sun et al., 2008; Herth &
Eberhardt, 2016) the search of a new alternative is justified. Medical management is not
sufficient and normally is necessary to perform invasive or minimally invasive procedures
in uncontrollable patients. These procedures include extra-luminal prosthesis (ELR) and
intra-tracheal stents (ITS). They both are available possibilities, but are not exempt from
complications. The most appropriate surgical treatment is still controversial. The main
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Figure 4 Macroscopic image of an implanted trachea shows no alteration of surrounding tissue. Ar-
row marks the fixation point of the prosthesis. Photo credit: Jose Rodriguez Gomez.
Full-size DOI: 10.7717/peerj.7797/fig-4
goal of tracheal collapse procedures is to give permanent support and retrieve the normal
anatomy without changing the luminal ciliary structure.
Placement of ELR requires invasive tracheal dissection and high morbidity has been
associated with its use for intra-thoracic collapse, for this reason now is contraindicated in
this localization (Chisnell & Pardo, 2015). Chisnell & Pardo (2015), studied 23 dogs treated
with ELR, complications arising tracheal dissection were 1/23 death during the procedure
and a 17% presented laryngeal paralysis.
A previous report (Tinga et al., 2015) of 73 dogs treated with ELR described a 42% of
major complications; short-term complications include a 26% death related to respiratory
compromise and 15% of laryngeal paralysis. In this study, long-term follow-up was
performed in 40 patients, with 15% of deaths associated with respiratory abnormalities
and 3% of laryngeal paralysis. Patients under ELR treatment were mostly cervical collapse
(60%), reported deaths were associated with the progression of this pathology and the
collapse of the entire trachea.
Similar laryngeal paralysis damage and deaths related to respiratory abnormalities have
been also reported (Becker et al., 2012). In this study, showed no survival difference between
dogs with simple cervical collapse with those with entire tracheal affectation. However,
other authors have reported significant differences (Chisnell & Pardo, 2015; Tinga et al.,
2015; Sun et al., 2008).
Even though our procedure requires some tissue dissection, there were no problems
associated with tracheal exposure. The CasMin-Twine procedure only requires one cm of
ventral dissection to expose cartilage rings, whereas the ELR needs 360◦ dissection affecting
surrounding tracheal structures and an experimented surgeon is required. Moreover,
total support of entire trachea is currently recommended (Clarke, 2018; Raske et al., 2018)
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Figure 5 Tracheal wall with a hole corresponding with the device. Discrete inflammatory reaction,
slight increase in globet cells. (B) Tracheal wall with a hole corresponding with the device and epithelial
absence. (C, D): Prosthesis-free area. Retains normal epithelial morphology and perfect ciliary structure.
Full-size DOI: 10.7717/peerj.7797/fig-5
and with the CasMin-Twine procedures, it is feasible to give support to both extra and
intra-thoracic trachea with a single spiral stent without having complications compared to
ELR.
An intra luminal prosthesis or stent can be manufactured with different materials,
silicone stents and metallic stents (MS) (Saito & Imamura, 2005; Folch & Keyes, 1998).
In human patients, the Food and Drug Administration (FDA) prohibited every kind of
metallic stents for benign airway disease due to the major complications and no recovery
possibility of the devices (Chung et al., 2011; Saito & Imamura, 2005; Folch & Keyes, 1998;
Onofre et al., 2008). Even though this warning, self-expanding mesh-shaped nitinol stents
(SEN) are the best available option for canine tracheal collapse (Weisse et al., 2008; Serrano
et al., 2016; Raske et al., 2018; Weisse et al., 2019). Silicon stents are not recommended in
veterinary practice due to the high migration and excessive mucus accumulation already
described (Onofre et al., 2008).
There is a small number of published studies which describe the stenting procedure
in canine tracheal collapse, and most of them reported similar complications: granuloma
formation, stent migration, severe mucus accumulation and stent fracture (Rosenheck et
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al., 2017; Serrano et al., 2016; Moritz, Schneider & Bauer, 2004; Raske et al., 2018; Weisse et
al., 2019; Saito & Imamura, 2005). A critical key point in this procedure is to choose precise
stent sizing and handicraft/surgical skills (Clarke, 2018).
The current recommendation is to overestimate stent diameter between 10–20% to
reduce migration, the measurement of tracheal diameter is essential, but also a complex
procedure (Sura & Krahwinkel, 2008; Rosenheck et al., 2017; Raske et al., 2018; Johnson,
Singh & Pollard, 2015). In our study with CasMin-Twine, it is not necessary to overestimate
the diameter of the device because the prosthesis is fixed by suture knot and not by radial
force.Wemeasured the tracheal diameterwithCT and the same size for stentwas implanted.
No migrations were present in controls; the fixing suture maintains the CasMin-Twine
device in position and this allowed not to have perfect precision in the diameter size
measurement.
In a study performed by Moritz, Schneider & Bauer (2004), 24 dogs underwent
endotracheal biliary Wallstent (auto-expandable stainless-steel stents) with an early
improvement of clinical signs and two deaths in the short-term. five patients of eighteen
(27.77%) developed granulomas and 83.3% of cases showed a shortening of the stent.
Currently, nitinol stents are recommended (Weisse et al., 2008; Clarke, 2018; Serrano et al.,
2016; Sun et al., 2008; Weisse et al., 2019); however, it presents similar results regarding
complication compared with MS, and also are not removable after endothelization (Saito
& Imamura, 2005). In our pilot, we obtained highly acceptable results with stainless steel
prosthesis, achieving better results than previous experiences in rabbit model (Serrano et
al., 2016). This device was retrievable even though endothelization without complications,
no-bleeding or tissue destruction occurs due to the new surgical approach.
CONCLUSION
The technical success in this study was optimal; it demonstrates the efficacy and low risk
arising from the surgery approach.
Tracheal tissue reactivity to the CasMin-Twine was minimized, and spiral shape allowed
to remove the stent without tissue damage.
Neither ITS nor ELR associated complications occurred in this study.
The limitations of this study were a small sample size as it was a pilot study with only ten
healthy animals, and finally its results could not be extrapolated directly to other animal
species or humans.
The satisfactory results obtained in comparrison with tracheal stent studies in the same
animal species (Serrano et al., 2016), give to veterinarians a new option for this complicated
pathology. Clinical trials and expanded analysis will be needed.
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